Revolutionary new cancer treatments are on the horizon. John Luk, Founder and President of Arbele, and Albert Wong, CEO of HKSTP, discuss how Hong Kong is nurturing advancements in precision therapy and how new biotech will help cancer patients live longer.
BE A 10X PIONEER
Join HKSTP and be a part of our innovation and tech ecosystem